Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
Aileen Faist, Sebastian Schloer, Angeles Mecate‐Zambrano, et al.
Antiviral Research (2022) Vol. 209, pp. 105475-105475
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

A review of cytokine-based pathophysiology of Long COVID symptoms
Russell N. Low, Ryan Low, Athena Akrami
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 101
Identifying the Potential of miRNAs in Houttuynia cordata-Derived Exosome-Like Nanoparticles Against Respiratory RNA Viruses
He Zhu, Mujun Chang, Qiulan Wang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 5983-6000
Open Access | Times Cited: 16
Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies
Said Moshawih, Qais Jarrar, Abdul Alim Bahrin, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25734-e25734
Open Access | Times Cited: 5
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
Host-targeted antivirals against SARS-CoV-2 in clinical development - prospect or disappointment?
André Schreiber, Stephan Ludwig
Antiviral Research (2025) Vol. 235, pp. 106101-106101
Open Access
VX-702 Ameliorates the Severity of Sepsis-Associated Acute Kidney Injury by Downregulating Inflammatory Factors in Macrophages
Yuexin Han, Jingyi Wang, Jin Zhang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4037-4054
Open Access | Times Cited: 3
Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19
Choon-Mee Kim, Jae Keun Chung, Sadia Tamanna, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1696-1696
Open Access | Times Cited: 3
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways
Aishwarya Jaiswal, Sanah Shrivastav, Hemant R. Kushwaha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The MAPK Response to Virus Infection Is Modified by Probenecid
Les Jones, David E. Martin, Ralph A. Tripp
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 246-246
Open Access
SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication
Christina A. Higgins, Benjamin E. Nilsson-Payant, Boris Bonaventure, et al.
mBio (2023)
Open Access | Times Cited: 7
Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics
Biswanath Dinda, Subhajit Dinda, Manikarna Dinda, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100173-100173
Open Access | Times Cited: 2
SARS-CoV-2 NSP14 induces AP-1 transcriptional activity via its interaction with MEK
Weiling Li, Yuansong Wang, Qian Peng, et al.
Molecular Immunology (2024) Vol. 175, pp. 1-9
Closed Access | Times Cited: 2
ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2
Wael L. L. Demian, Rajesh Jacob, Olga Cormier, et al.
Antiviral Research (2023) Vol. 220, pp. 105736-105736
Open Access | Times Cited: 5
The Immunosuppressive Roles of PD-L1 during Influenza A Virus Infection
Hongya Ning, Shih-Hsin Chiu, Xiaodong Xu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8586-8586
Open Access | Times Cited: 4
Duck Tembusu virus infection activates the MKK3/6-p38 MAPK signaling pathway to promote virus replication
Yuting Cheng, Linlin Jiao, Jinying Chen, et al.
Veterinary Microbiology (2023) Vol. 288, pp. 109951-109951
Open Access | Times Cited: 4
Comparative analysis of <i>MxA, OAS1, PKR</i> gene expression levels in leukocytes of patients with influenza and coronavirus infection
С. А. Клотченко, Ekaterina A. Romanovskaya-Romanko, Veronika A. Oleynik, et al.
Medical academic journal (2024) Vol. 23, Iss. 3, pp. 65-75
Closed Access | Times Cited: 1
Repression of mRNA translation initiation by GIGYF1 via disrupting the eIF3-eIF4G1 interaction
Jung‐Hyun Choi, Jun Luo, Geoffrey G. Hesketh, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 1
Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro
Débora Bublitz Anton, Jeferson Camargo de Lima, Bruno Rampanelli Dahmer, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3007-3035
Closed Access | Times Cited: 1
Molecular characterisation of influenza B virus from 2017/18 season in primary models of human lung reveals improved adaption to the lower respiratory tract
Duygu Merve Çalışkan, Sriram Kumar, Saskia Hinse, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The Journey of p38 MAP Kinase Inhibitors: From Bench to Bedside in Treating Inflammatory Diseases
Fuwei Yang, Zhao Lijie, Q. Alan Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116950-116950
Closed Access | Times Cited: 1
MEK-inhibitor treatment reduces the induction of regulatory T cells in mice after influenza A virus infection
Julia Koch-Heier, Annette B. Vogel, Yvonne Füll, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Large-Scale Biomedical Relation Extraction Across Diverse Relation Types: Model Development and Usability Study on COVID-19
Zeyu Zhang, Meng Fang, Rebecca Wu, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e48115-e48115
Open Access | Times Cited: 3
Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response
Yining Wang, Pengfei Li, Lei Xu, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107631-107631
Open Access | Times Cited: 2
Serum proteome reveals distinctive molecular features of H7N9- and SARS-CoV-2-infected patients
Yunzhi Wang, Zhigang Song, Peng Ran, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114900-114900
Open Access
Repression of mRNA translation initiation by GIGYF1 via blocking the eIF3-eIF4G1 interaction
Jung‐Hyun Choi, Jun Luo, Geoffrey G. Hesketh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top